This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Jul 3:339:b1645.

doi: 10.1136/bmj.b1645.

Imuunosuppressants, mortality, and risk of cancer

Jerry Avorn, Sebastian Schneeweiss

PMID: 19578084
DOI: 10.1136/bmj.b1645

Editorial

Imuunosuppressants, mortality, and risk of cancer

Jerry Avorn et al. BMJ. 2009.

. 2009 Jul 3:339:b1645.

doi: 10.1136/bmj.b1645.

Authors

Jerry Avorn, Sebastian Schneeweiss

PMID: 19578084
DOI: 10.1136/bmj.b1645

No abstract available

PubMed Disclaimer

Comment on

Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study.
Kempen JH, Daniel E, Dunn JP, Foster CS, Gangaputra S, Hanish A, Helzlsouer KJ, Jabs DA, Kaçmaz RO, Levy-Clarke GA, Liesegang TL, Newcomb CW, Nussenblatt RB, Pujari SS, Rosenbaum JT, Suhler EB, Thorne JE. Kempen JH, et al. BMJ. 2009 Jul 3;339:b2480. doi: 10.1136/bmj.b2480. BMJ. 2009. PMID: 19578087 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.